Skip to main content

Table 1 Demographic and clinical characteristics of ATF in MDD patients

From: Prevalence and clinical profile of abnormal glucose in first-episode and drug-naïve patients with major depressive disorder with comorbid abnormal thyroid function: a large-scale cross-sectional study

Variable

ATF (n=1044)

NTF (n=674)

F, Z or χ2

P

Male, n (%)

358(34.3)

230(34.1)

0.005

0.985

Education, n (%)

  

3.387

0.336

1

263(25.2)

150(22.3)

  

2

451(43.2)

309(45.9)

  

3

267(25.6)

182(27.0)

  

4

63(6.0)

33(4.9)

  

Married, n (%)

760(72.8)

456(67.7)

4.99

0.026

Suicide, n (%)

263(25.2)

83(12.3)

41.43

< 0.001

Severe anxiety, n (%)

160(15.3)

44(6.5)

29.46

< 0.001

Exhibiting psychotic symptoms, n (%)

136(13.0)

35(5.2)

27.18

< 0.001

Abnormal glucose, n (%)

494(47.3)

117(17.4)

159.11

< 0.001

Duration of disease, month

7.00(4.85)

5.23(4.33)

59.06

< 0.001

Actual age, year

35.68(12.42)

33.61(12.34)

11.44

0.001

Actual age group

  

14.4

0.001

18–39, n (%)

605 (58)

451 (66.9)

  

40–49, n (%)

267 (25.6)

129 (19.1)

  

≥ 50, n (%)

172 (16.5)

94 (13.9)

  

Age of onset, year

35.44(12.28)

33.45(12.28)

10.72

0.001

HAMD

31.23(2.72)

28.86(2.69)

313.74

< 0.001

HAMA

21.18(3.64)

20.21(3.12)

32.40

< 0.001

PANSS

9.47(4.94)

7.89(3.15)

54.13

< 0.001

Fasting blood glucose (mmol/L)

5.60(0.63)

5.09(0.55)

291.60

< 0.001

Fasting blood glucose group

  

161.08

< 0.001

< 5.6 mmol/L, n (%)

550 (52.7)

557 (82.6)

  

5.6–6.9 mmol/L, n (%)

471 (45.1)

114 (16.9)

  

≥ 7 mmol/L, n (%)

23 (2.2)

3 (0.4)

  

BMI, kg/m 2

24.62(1.99)

23.97(1.75)

48.08

< 0.001